IGFBP-2 expression in MCF-7 cells is regulated by the PI3K/AKT/mTOR pathway through Sp1-induced increase in transcription

References

• Baxter R. 1993. Circulating binding proteins for the insulin-like growth factors. Trends Endocrinol Metab. 4:91–96.
   PubMedGoogle Scholar
• Beck T, Hall MN. 1999. The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature. 402:689–692.
   PubMed Web of Science ®Google Scholar
• Blume-Jensen P, Hunter T. 2001. Oncogenic kinase signalling. Nature. 411:355–365.
   PubMed Web of Science ®Google Scholar
• Boisclair YR, Brown AL, Casola S, Rechler MM. 1993. Three clustered Sp1 sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat. J Biol Chem. 268:24892–24901.
   PubMedGoogle Scholar
• Boulle N, Logie A, Gicquel C, Perin L, Le Bouc Y. 1998. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors. J Clin Endocrinol Metab. 83:1713–1720.
   PubMed Web of Science ®Google Scholar
• Busund LT, Richardsen E, Busund R, Ukkonen T, Bjornsen T, Busch C, Stalsberg H. 2005. Significant expression of IGFBP2 in breast cancer compared with benign lesions. J Clin Pathol. 58:361–366.
   PubMed Web of Science ®Google Scholar
• Campbell PG, Durham SK, Hayes JD, Suwanichkul A, Powell DR. 1999. Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin. J Biol Chem. 274:30215–30221.
   PubMed Web of Science ®Google Scholar
• Chan TW, Pollak M, Huynh H. 2001. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780. Clin Cancer Res. 7:2545–2554.
   PubMedGoogle Scholar
• Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CT, Fontana JA. 1994. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-1 (IGF-1)-mediated DNA synthesis and IGF-1 binding in a human breast carcinoma cell line. J Cell Physiol. 158:69–78.
   PubMedGoogle Scholar
• Chesik D, De Keyser J, Wilczak N. 2007. Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: Implications in multiple sclerosis. Cytokine Growth Factor Rev. 18:267–278.
   PubMed Web of Science ®Google Scholar
• Courey AJ, Tjian R. 1988. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell. 55:887–898.
   PubMed Web of Science ®Google Scholar
• Drop SLS, Schuller AGP, Lindenbergh-Kortleve DJ, Groffen C, Brinkman A, Zwarthoff EC. 1992. Structural aspects of the IGFBP family. Growth Regul. 2:69–79.
   PubMedGoogle Scholar
• Dunlap SM, Celestino J, Wang H, Jiang R, Holland EC, Fuller GN, Zhang W. 2007. Insulin-like growth factor binding protein 2 promotes glioma development and progression. Proc Natl Acad Sci USA. 104:11736–11741.
   PubMed Web of Science ®Google Scholar
• Dutcher JP, Coletti D, Paietta E, Wiernik PH. 1997. A pilot study of alpha-interferon and plicamycin for accelerated phase of chronic myeloid leukemia. Leuk Res. 21:375–380.
   PubMed Web of Science ®Google Scholar
• Elminger MW, Bell M, Schuett BS, Langkamp M, Kutoh E, Ranke MB. 2001. Transactivation of the IGFBP-2 promoter in human tumor cell lines. Mol Cell Endocrinol. 175:211–218.
   PubMedGoogle Scholar
• Ernst CW, White ME. 1996. Hormonal regulation of IGF-binding protein-2 expression in proliferating C2C12 myoblasts. J Endocrinol. 149:417–429.
   PubMedGoogle Scholar
• Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 23:824–854.
   PubMed Web of Science ®Google Scholar
• Fottner C, Sattarova S, Hoffmann K, Spottl G, Weber MM. 2008. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: Correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin. Eur J Endocrinol. 159:317–327.
   PubMedGoogle Scholar
• Frommer KW, Reichenmiller K, Schutt BS, Hoeflich A, Ranke MB, Dodt G, Elmlinger MW. 2006. IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. J Mol Endocrinol. 37:13–23.
   PubMed Web of Science ®Google Scholar
• Gingras AC, Raught B, Sonenberg N. 2004. mTOR signaling to translation. Curr Top Microbiol Immunol. 279:169–197.
   PubMed Web of Science ®Google Scholar
• Han HJ, Kang CW, Park SH. 2006. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro. Clin Exp Pharmacol Physiol. 33:1172–1179.
   PubMedGoogle Scholar
• Hardwick JS, Kuruvilla FG, Tong JK, Shamji AF, Schreiber SL. 1999. Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc Natl Acad Sci USA. 96:14866–14870.
   PubMed Web of Science ®Google Scholar
• Hoeflich A, Lahm H, Blum W, Kolb H, Wolf E. 1998. Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines. FEBS Lett. 434:329–334.
   PubMedGoogle Scholar
• Hoeflich A, Fettscher O, Lahm H, Blum WF, Kolb HJ, Engelhardt D, Wolf E, Weber MM. 2000. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. Cancer Res. 60:834–838.
   PubMedGoogle Scholar
• Hoeflich A, Reisinger R, Lahm H, Kiess W, Blum WF, Kolb HJ, Weber MM, Olf E. 2001. Insulin-like growth factor-binding protein 2 in tumorigenesis: Protector or promoter?. Cancer Res. 61:8601–8610.
   PubMed Web of Science ®Google Scholar
• Hwa V, Oh Y, Rosenfeld RG. 1999. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 20:761–787.
   PubMed Web of Science ®Google Scholar
• Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev. 16:3–34.
   PubMed Web of Science ®Google Scholar
• Kennedy BJ, Torkelson JL. 1995. Long-term follow-up of stage III testicular carcinoma treated with mithramycin (plicamycin). Med Pediatr Oncol. 24:327–328.
   PubMedGoogle Scholar
• Lalou C, Lassarre C, Binoux M. 1996. Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3. Horm Res. 45:156–159.
   PubMedGoogle Scholar
• Levitt RJ, Georgescu MM, Pollak M. 2005. PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2. Biochem Biophys Res Commun. 336:1056–1061.
   Google Scholar
• Majumdar G, Harrington A, Hungerford J, Martinez-Hernandez A, Gerling IC, Raghow R, Solomon S. 2006. Insulin dynamically regulates calmodulin gene expression by sequential o-glycosylation and phosphorylation of sp1 and its subcellular compartmentalization in liver cells. J Biol Chem. 281:3642–3650.
   PubMedGoogle Scholar
• Martin JL, Baxter RC. 2007. Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Endocrinology. 148:2532–2541.
   PubMedGoogle Scholar
• Mayer C, Zhao J, Yuan X, Grummt I. 2004. mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev. 18:423–434.
   PubMed Web of Science ®Google Scholar
• McDonald KL, O'Sullivan MG, Parkinson JF, Shaw JM, Payne CA, Brewer JM, Young L, Reader DJ, Wheeler HT, Cook RJ, Biggs MT, Little NS, Teo C, Stone G, Robinson BG. 2007. IQGAP1 and IGFBP2: Valuable biomarkers for determining prognosis in glioma patients. J Neuropathol Exp Neurol. 66:405–417.
   PubMedGoogle Scholar
• Menouny M, Binoux M, Babajko S. 1998. IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity. Int J Cancer. 77:874–879.
   PubMedGoogle Scholar
• Mohan S, Baylink DJ. 2002. IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol. 175:19–31.
   PubMed Web of Science ®Google Scholar
• Okabe E, Kajihara J, Usami Y, Hirano K. 1999. The cleavage site specificity of human prostate specific antigen for insulin-like growth factor binding protein-3. FEBS Lett. 447:87–90.
   PubMedGoogle Scholar
• Parker A, Rees C, Clarke J, Busby WHJr, Clemmons DR. 1998. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. Mol Biol Cell. 9:2383–2392.
   PubMed Web of Science ®Google Scholar
• Perks CM, Vernon EG, Rosendahl AH, Tonge D, Holly JM. 2007. IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells. Oncogene. 26:5966–5972.
   PubMed Web of Science ®Google Scholar
• Richardsen E, Ukkonen T, Bjornsen T, Mortensen E, Egevad L, Busch C. 2003. Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium. Virchows Arch. 442:329–335.
   PubMedGoogle Scholar
• So A, Levitt RJ, Eigl B, Fazil L, Muramaki M, Leung S, Cheang M, Nielsen T, Gleave M, Pollak M. 2008. Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer. Clin Cancer Res. 14:6944–6954.
   PubMedGoogle Scholar
• Solomon SS, Majumdar G, Martinez-Hernandez A, Raghow R. 2008. A critical role of Sp1 transcription factor in regulating gene expression in response to insulin and other hormones. Life Sci. 83:305–312.
   PubMed Web of Science ®Google Scholar
• Sommer A, Spratt SK, Tatsuno GP, Tressel T, Lee R, Maack CA. 1993. Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3). Growth Regul. 3:46–49.
   PubMedGoogle Scholar
• Tan NY, Khachigian LM. 2009. Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol. 29:2483–2488.
   PubMed Web of Science ®Google Scholar
• Yu J, Iwashita M, Kudo Y, Takeda Y. 1998. Phosphorylated insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) inhibits while non-phosphorylated IGFBP-1 stimulates IGF-I-induced amino acid uptake by cultured trophoblast cells. Growth Horm IGF Res. 8:65–70.
   PubMed Web of Science ®Google Scholar
• Zumkeller W, Schwander J, Mitchell CD, Morrell DJ, Schofield PN, Preece MA. 1993. Insulin-like growth factor (IGF)-I, -II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms' tumor. Eur J Cancer. 29A:1973–1977.
   PubMedGoogle Scholar